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This report describes the fragmentation processes for peptides induced by collisional activa- 
tion of the “C isobar of matrix-assisted laser desorption ionization (MALDIJ-generated 
pseudomolecular ions employing an EBE orthogonal acceleration time-of-flight mass spec- 
trometer and using xenon as the collision gas at a laboratory collision energy of 800 eV. These 
MALDI-collision-induced dissociation (CID) spectra are shown to provide sequence infor- 
mation of comparable quality to those obtained by using high energy CID conditions with 
liquid secondary ionization mass spectrometry on a four-sector tandem instrument. Peptide 
sequencing via MALDI-CID is demonstrated on three tryptic peptides obtained from a 
bacterial protein (P450 isozyme) of unknown sequence. Sensitivity is shown to be at the 
1 pmol level for standard peptides. (J Am Sot Mass Speclrouz 2996, 7, l-20) 
0 
ver the past few years the discovery of soft 
ionization techniques has revolutionized the 
ways that problems in protein biochemistry 
may be tackled through the use of a variety of new 
mass spectrometric methods and instrumentation. 
Progress has been widespread and rapid, from the 
molecular weight mapping of protein digests to the 
amino acid sequence determination and the structural 
characterization of covalent modifications (for reviews, 
see [l] and [Zl). 
Because these soft ionization techniques tend to 
form ions by protonation-deprotonation of the neutral 
molecule with low vibrational energy content, signals 
due to the intact pseudomolecular ion(s) are observed, 
which provides a sensitive means for determination of 
the molecular weights and purity of substances or the 
composition of mixtures. In addition, some fragments 
are observed in the cases of liquid secondary ioniza- 
tion (LSI) and matrix-assisted laser desorption ioniza- 
tion (MALDI) as well, although the fragments are of 
unpredictable qualitative nature and relative abun- 
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dance. To exploit fully a mass spectrometric strategy 
for structural elucidation of such gas-phase molecular 
species, enhancement of their vibrational energy is 
required to induce unimolecular dissociation to frag- 
ments that are characteristic of the structure of the 
molecule. This is accomplished readily, for example, 
by collision with an inert gas such as helium, followed 
by a second stage of mass analysis to record the 
fragment ions thus generated, which yields collision- 
induced dissociation (CID) spectra. Two distinct colli- 
sion regimens are in common use: so-called low en- 
ergy and high energy; they impart different amounts 
of internal energy, which results in the induction of a 
variety of ion types, some of which are unique to the 
high energy process [3]. These high energy ion types 
have been shown to be of considerable value in the de 
uouo determination of complete and unambiguous 
amino acid sequence [4, 51. 
Because matrix-assisted laser desorption ionization 
(MALDI) is believed to provide the highest ionization 
efficiency for peptides, it is of major importance for 
protein characterization [6] and has been used for 
digest mapping and identification of proteins isolated 
from two-dimensional gels [7, 81. Although mapping 
strategies have enjoyed some success and utility in 
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connection with identification of known proteins in cell 
lysates through database searching [71, it is of consid- 
erable importance to be able to generate high quality 
reproducible CID spectra with the inherent informa- 
tion content for direct sequence and structural analy- 
sis. For this purpose, the development of a combina- 
tion of the high ionization efficiency of MALDI with 
the high resolution and mass accuracy of double-focus- 
ing instruments should provide the high’ energy CID 
information sought. A tandem mass spectrometer that 
is compatible with pulsed ionization techniques and 
consists of a double-focusing instrument and a co-lin- 
ear time-of-flight analyzer with a reflectron has been 
described by Russell’s group [9, 101. The same group 
reported a CID spectrum of the MALDI-generated 
molecular ion of angiotensin II (10 pmoles loaded) [ill 
acquired on this instrument [12]. This CID spectrum 
showed very unusual fragmentation, which suggested 
that the accuracy of mass measurement as well as the 
resolution would need improvement. In addition, by 
using MALDI, the CID spectrum of substance P has 
been recorded with xenon as a collision gas on a 
four-sector instrument with array detection [13]. In a 
further preliminary report, the MIT group 1141 has 
presented the photodissociation spectra of substance P 
and renin substrate from MALDI experiments. 
Synthetic Pep tides 
The I-IPLC purified peptides were dissolved in water 
to yield a concentration of approximately S-10 
pmol/pL. The same sample amount, approximately 
0.5 ILL, was loaded for each experiment. 
Muss Spectrometry 
The primary molecular mass determination of the frac- 
tions and the synthetic peptides and the PSD experi- 
ment were performed on a VG TofSpec SE 
MALDI-time-of-flight (TOF) mass spectrometer (VG 
Analytical Ltd., Manchester, UK). One microliter of 
each I-IPLC fraction was mixed with 1 PL of 4-hy- 
droxy-a-cyano-cinnamic acid matrix or 2,5-dihydroxy- 
benzoic acid (DHB) solution (Hewlett-Packard, Palo 
Alto, CA), and half of this mixture was loaded onto the 
sample cylinder. 
In this article we report the sequence analysis of 
peptides by using MALDI and a new ion optical strat- 
egy based on a tandem instrument comprised of an 
EBE geometry for MS-l and an orthogonal acceleration 
time-of-flight analyzer for MS-2 [15]. This instrumenta- 
tion provides the means to generate high energy CID 
spectra from MALDI pseudomolecular ions with 
monoisotopic precursor ion selection, and holds 
promise for the characterization of unknown proteins 
available in the femtomole range. In addition, both 
liquid secondary ion mass spectrometry (LSIMS) four- 
sector high energy CID and MALDI postsource decay 
(PSD) mass spectra are presented on synthetic peptides 
for comparative evaluation. 
Experimental 
One microliter of each HPLC fraction and 1 PL of 
4-hydroxy-a-cyano-cinnamic acid matrix solution 
(saturated in a water/acetonitrile 70:30 mixture acidi- 
fied with 0.1% TFA) were mixed and loaded for 
MALDI-CID analysis. These experiments were per- 
formed on a VG AutoSpec 5000 orthogonal accelera- 
tion (oa)-TOF tandem mass spectrometer. Figure 1 
shows the ion optical design of this instrument. MS-1 
is a VG AutoSpec 5000 double-focusing magnetic sec- 
tor mass spectrometer equipped with a MALDI source. 
The N, laser (337 run wavelength) used in the MALDI 
source typically is operated at 10 Hz pulse rate. MS-1 
is tuned to transmit just the “C monoisotopic ions of 
the precursor mass. Figure 2 shows an enlarged 
schematic of the gas collision cell and orthogonal accel- 
eration-TOF housing. A two-stage deceleration elec- 
trostatic lens focuses the ions into an approximately 
parallel beam before they enter the gas collision cell 
(1 = 5 cm). Using xenon as the collision gas and a 
collision energy of 800 eV, the pressure in the cell was 
adjusted such that the selected precursor species was 
reduced to approximately 30% of its value without gas 
in the collision cell. Previous measurements on renin 
Tryptic Peptides 
Approximately 100 pmol of a purified soluble un- 
known bacterial I’450 protein were incubated with 
trypsin (4% w/w; Worthington, Freehold, NY) in 50 
mM NH,HCO, buffer (pH 7.8) at 37 “C for 18 h. The 
tryptic peptides were separated by reversed-phase 
high-performance liquid chromatography (HFLC) on a 
microbore Cl8 column (250 X 1 mm; Vydac, Hesperia, 
CA) by using 0.1% trifluoroacetic acid (TFA) in water 
as solvent A and 0.08% TFA in acetonitrile as solvent 
B. The amount of solvent B was increased by 1% per 
minute during the gradient elution. The column ef- 
fluent was monitored at 215 run. Fractions were col- 
lected manually and used for mass spectrometric anal- 
yses as described in subsequent text. 
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Figure 1. Ion optical configuration of the VG AutoSpec-oa-TOF. 
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Figure 2. Schematic of the gas collision cell and the orthogonal 
acceleration-TOF. 
substrate that used LSIMS established that attenuation 
of the selected ion by 30% corresponded to the ion 
gauge reading given in the following text. The calcu- 
lated probability at 30% attenuation is 36% one- and 
22% two-ion xenon atom collisions for precursor ions 
that transit the gas cell [16, 171. Under these circum- 
stances the indicated average pressure on the ion gauge 
is 1.2 x 10m6 mbar, which corresponds to a true pres- 
sure for xenon of approximately 4.0-5.5 X lo-’ mbar. 
The resulting mixture of precursor and product ions 
passes through the orthogonal acceleration chamber, 
which is normally field-free, but in which an electric 
field orthogonal to the direction of travel is established 
periodically by the sudden application of a voltage to 
the “push-out” electrode. The required precision for 
the timing of this extraction field is not excessive; for 
example, for precursor ions of mass 1000 u and a 
collision energy of 800 eV the required delay time is 75 
ps, with a transit window of 2 ps. This delay time is 
automatically calculated and controlled by the data 
system. The ions in the extraction field at this time are 
accelerated to ground potential through a two-stage 
voltage gradient into a linear TOF mass analyzer. The 
linear TOF has an effective path length of approxi- 
mately 0.48 m. The extraction pulse also denotes the 
start of the time-of-flight measurement. When these 
ions have left the orthogonal acceleration chamber, the 
push-out voltage is reset and ready for the next laser 
pulse. For this mode of operation the sampling effi- 
ciency is lOO%, which leaves no residual signal to be 
observed on detector 2. The TOF detector consists of 
3 X 50 mm long multichannel (MCI’) plates (total 
length of 150 mm). MS-2 always automatically records 
the full product ion spectrum irrespective of the pre- 
cursor ion mass selected by MS-l. The ion signal from 
the microchannel plate detector is acquired by using a 
time-to-digital convertor (TDC) supplied by Precision 
Instruments (Knoxville, TN). The TDC acquisition rate 
is 1 GHz and data are summed in real time into a 32K 
word length histogram, which thereby allows acquisi- 
tions up to 32.7 ps. For a source voltage of 8 kV and a 
collision energy of 800 eV, the mass range accommo- 
dated within the 32.7-ps flight time is 7200 u. 
Time-of-flight calibration. All the fragment ions from 
the gas cell have essentially the same forward velocity 
component (zJ,). They all are accelerated exactly or- 
thogonally with the same voltage <V,,> to have the 
same energy CeV,), and hence all fragment ions have 
an orthogonal velocity component (v,,) proportional to 
J(eV,/m). This means that all fragment ions have an 
orthogonal velocity component that is inversely pro- 
portional to the square root of the mass-as with 
normal time-of-flight analyzers-and all have the same 
orthogonal distance to travel to the plane of the detec- 
tor. The fact that the ions also continue to drift forward 
as they travel to the detector is of no consequence to 
their time-of-flight, only to where they hit the detector. 
(Hence the need for a long detector.) Consequently, 
there is no need to apply any sort of correction to the 
normal time-of-flight calibration table. We have found 
that a two-point calibration works well, although it is 
our normal practice to generate a multipoint calibra- 
tion from the product ion spectrum of m/z 3510 of 
cesium iodide. 
The LSIMS-CID spectra were acquired on a Kratos 
Analytical (Manchester, UK) Concept tandem mass 
spectrometer of EBEB geometry, equipped with a con- 
tinuous flow frit probe and a rapid scanning charge 
coupled device (CCD) detector (3 s/decade) [B, 181. A 
mixture of 5% thioglycerol, 5% acetonitrile, and 0.1% 
TFA in water was used as the liquid matrix at a flow 
rate of 3 ~L/rnin. 
Results 
Synthetic and Standard Peptides 
A synthetic major histocompatability (MHC) peptide 
(APRTLVLLL, MI-I+ at m/z 995.6) was selected for 
evaluation of the ion types observed in MALDI-CID as 
well as for comparison with the well established 
LSIMS-CID and the newly emerging MALDI-ESD tech- 
nique. These spectra are shown in Figure 3a, b, and c, 
respectively. All spectra exhibit N-terminal fragment 
ions as expected because of the preferential charge 
retention at the Arg residue, as well as internal frag- 
ments. Each spectrum provides information on the 
amino acid composition in the form of immonium 
ions, but only the LSIMS-CID spectrum (panel b) shows 
abundant fragments due to side-chain losses from the 
pseudomolecular ion. The MALDI-CID spectrum 
(panel a) shows a complete d ion series at m/z 382 
and 384 cd,, Thr residues may yield two d fragments), 
469 cd,), 596 cd,), 681 cd,), 794 cd,), and 908 cd,). This 
spectrum also features abundant ions due to sequen- 
tial neutral losses. These latter ions are similar to those 
observed in the PSD spectrum (panel cl described in 
subsequent text. For example, fragments PRT-17-18 at 
m/z 320, b,-17-18 at m/z 391, and b,-17-18 at m/z 
504 belong to this ion-type series. In the LSIMS-CID 
spectrum (panel b) the dominating fragments are a 
ions and the corresponding side-chain fragment d ions. 
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Figure 3. Fragmentation pattern of synthetic 
MHC peptide APRTLVLLL (MH+ at m/z 
995.6) by (a) MALDI-CID, (b) LSIMS-CID, and 
(c) MALDI-PSD. 
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Figure 4. (a) MALDI-CID and (b) LSIMS- 
CID of synthetic peptide HLDVLQ (MHf 
at m/z 724.4). 
This spectrum also exhibits a few ions formed via 
neutral losses, mostly NH, losses (- 17 u). In the PSD 
spectrum (panel c) abundant ions are present due to 
sequential neutral losses from a and b ions as well as 
from internal fragments. Although this spectrum ex- 
hibited ions at masses that correspond to putative ions 
da and d,, it remains to be established whether this is 
in fact the case or whether they represent neutral loss 
or other unknown processes, because PSD spectra are 
not known to feature side-chain fragment ions. 
The MALDI-CID and LSIMS-CID spectra of syn- 
thetic peptide (HLDVLQ, MI-I+ at m/z 724.4) are 
presented in Figure 4a and b, respectively. The His 
residue, similarly to Arg, is a basic amino acid that 
retains the proton and thus controls the fragmentation. 
As expected, this peptide yields mostly N-terminal 
ions. The MALDI-CID spectrum (panel a) gives immo- 
nium ions but lacks the fragments due to side-chain 
losses from the pseudomolecular ion. In this spectrum 
only d, and d, were detected from among the d ions, 
and even their relative abundance is much lower than 
in the LSIMS-CID spectrum (panel b). The LSIMS-CID 
spectrum (panel b) exhibits abundant immonium ions 
and fragments due to the Leu and Gln side-chain 
cleavages from the pseudomolecular ion. The spec- 
trum shows complete a and b ion series and the 
corresponding satellite d ions at m/z 181 cd,), 294 
(da), 423 (d,), 508 cd,), and 621 cd,). Substituting Lys 
as the N-terminal amino acid of this peptide instead of 
His, only d, and d, were detected with similarly low 
abundance in the MALDI-CID analysis, whereas the 
LSIMS-CID spectrum exhibited a complete d series 
(data not shown). 
MALDI-CID and LSIMS-CID spectra of another syn- 
thetic MI-K peptide (LVMAPRTVL, MH+ at m/z 
999.6) are shown in Figure 5a and b, respectively. Both 
spectra exhibit ions (v, w, and d fragments) that are 
usually observed only under high energy collision 
conditions. However, there are some obvious differ- 
ences, not only in the relative intensities of the differ- 
ent ions, but in the presence or absence of certain types 
of fragments. While this is of little interpretative value, 
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Figure 5. (a) MALDI-CID and (b) LSIMS-CID 
of synthetic MHC peptide LVMAPRTVL 
(MH’ at m/z 999.6). . - 
once again the most striking difference is the lack of 
side-chain losses from the pseudomolecular ion in the 
MALDI-CID spectrum (panel a). The other interesting 
feature of this spectrum is a very abundant ion at m/z 
568 (i.e., ys - 17). Ions at m/z yi - 17 usually are 
considered to be zi ions. However, z ion formation 
requires a bond cleavage between the amino group 
and the a-carbon of the amino acid. Because the fifth 
amino acid (starting from the C-terminus) is a Pro 
residue (an imino acid), this species cannot be a z ion, 
but rather is the result of some other fragmentation 
processes. The loss of 17 u (most likely NH,) from 
Arg-containing ions has been described previously, 
primarily in low energy CID spectra [191, but also has 
been reported in some high energy CID experiments 
(Figure 3b) [51. 
To evaluate the quality of MALDI-CID spectra for a 
given number of laser shots from limited sample 
amounts, the CID spectrum of another synthetic MHC 
peptide (SPRYIFTML, MI-I+ at m/z 1127.6) obtained 
m/z 
from 500 shots is shown in Figure 6. The immonium 
ions reveal the amino acid composition of the peptide 
[20]. From the sequence and satellite ions the order of 
the five N-terminal amino acids can be determined 
readily, and although the d, ion was not detected, a 
d 6, ,le at m/z 708 identifies the fifth amino acid as Ile 
[21]. The rest of the sequence can be deciphered mostly 
from the satellite and internal fragments. No d, ion 
was observed in this spectrum; thus the C-terminal 
amino acid could be either of the isobaric Leu-Ile pair. 
As an additional indication of the sensitivity that 
may be achieved’ readily with this new technique, the 
CID spectra of two standard peptides that are com- 
monly used in many laboratories have been recorded 
by loading 1 pmol of each. The MALDI-CID spectrum 
of substance P by using 2,5-dihydroxybenzoic acid 
(DHB) as the solid matrix is shown in Figure 7. This 
spectrum shows some of the features described above: 
(1) lack of side-chain fragments from the pseudomolec- 
ular ion, except -Q/K; (2) neutral losses from a and b 
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Figure 6. MALDI-CID spectrum of synthetic MHC 
peptide SPRYIFIML fMH+ at m/z 1127.61, obtained 
from 500 laser shots at a single spot on the target 
loaded with - 5 pmol peptide. 
ions; (3) satellite ions, which are commonly observed 
in LSIMS high energy CID spectra from instruments of 
varying geometry (for comparison, see Table III in ref 
221. Figure 8 shows the MALDI-CID spectrum of renin 
substrate. As is the case for its LSIMS high energy CID 
spectrum, this MALDI-CID spectrum exhibits a com- 
plete d ion series. 
Peptides from Unknown Protein 
The tryptic digest of an unknown soluble bacterial 
I’450 protein was separated on a microbore Cl8 col- 
umn. The fractions were collected manually and 1 PL 
of each was analyzed by MALDI-TOF mass spectrome- 
try, in reflectron mode, by using 4-hydroxy-ol-cyano- 
cinnamic acid as the solid matrix. These unknown 
tryptic peptides were subjected to MALDI-CID analy- 
sis. The CID spectra of three components will serve to 
illustrate their interpretation. The pseudomolecular 
ions are at m/z 781.4 and 997.6 from fraction 12 and at 
m/z 876.5 from fraction 16 (chromatogram not shown). 
Figure 9 shows the MALDI-CID spectrum of the pep- 
tide with MI-I+ at m/z 781.4. The ions in the low mass 
region are significantly more abundant than those at 
.I-.40 .-  - 
Figure 7. MALDI-CID spectrum of 1 pmol 
(loaded) substance P (RPKPQQFFGLM-NH,) 
with DHB as the solid matrix. Fragment ions 
labeled with asterisks are present due to neutral 
- losses f-17) from a and b sequence ions. Un- 
L usual satellite ions a, + 1 - Q and d,,o were 
Irn zm tm 402 m bm 7m 8m pm ,aa !,rn ,m IJm mix observed at m/z 783 and 797, respectively. 
higher masses. Although the amino acid composition 
can be determined readily from the immonium ions 
present-m/z 59,70,87, 100, and 112 for Arg; m/z 60 
for Ser; m/t 72 for Val; m/z 120 for Phe; m/z 130, 
159, 170 for Trp [20]-no side-chain losses from the 
molecular ion were detected. The spectrum shows 
abundant ions with charge retention on both the C- 
and the N-termini. The sequence was determined as 
follows [5]: First the presence of the C-terminal Arg 
was established from the immonium ions and y, at 
m/z 175 consistent with the specificity of trypsin. The 
presence of a v2 ion at m/z 230 without the accompa- 
nying w2 fragment indicated an aromatic amino acid 
N-terminal to the Arg. Additional fragment ions at 
m/z 344 (z,) and 361 (yz) require this amino acid to be 
Trp. Similarly, ions at m/z 416 (v,), 491 (z,>, and 508 
(ys) revealed the next amino acid to be Phe. The order 
of the remaining three N-terminal amino acids was 
determined from the N-terminal fragment ions ob- 
served at m/z 147 (a,), 256 (a,), and 274 (b,), and 
supported by weak C-terminal fragments at m/z 590 
(z,> and 678 (z, + 11. The ion at m/z 421 is fragment 
b,, whereas that at m/z 625 corresponds to b, + H,O. 
The sequence of this peptide is Ser-Ser-Val-Phe-Trp- 
Arg. 
+ 1148 r 
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Figure 8. MALDI-CID spectrum of 1 pmol 
(loaded) renin substrate (DRVYIHPFHLLVYS) 
with DHB as the solid matrix. 100 xa 
Figure 10 shows the MALDI-CID spectrum for the 
peptide with MH+ at m/z 997.6. The immonium ion 
region clearly indicates the presence of Arg, Val, Met, 
Phe, and Tyr. Pro (immonium ion at m/z 70) and Asn 
(87) also could be present, but the presence of these 
amino acids may be masked by isobaric ions that arise 
from the Arg. The sequence was determined based 
upon the C-terminal satellite ion series, by drawing 
conclusions from the presence or absence of v and w 
ions [5]. For example, the absence of v2 or w2 ions 
suggested the presence of Gly or Ala in the penulti- 
mate position, whereas the v3 (at m/z 287) and w3 (at 
m/r 300) pair indicated the presence of a P-sub- 
stituted amino acid, which must be Val, because the 
two other amino acids that bear a /3-substituent (Thr 
and Ile) are not present in this particular peptide 
(deduced from the lack of the corresponding immo- 
nium ions). Side-chain fragments were detected for all 
the amino acids that would be expected by considering 
known fragmentation pathways [21], such as Met at 
m/z 385 (w,) and 470 (zs + 1 - SCH,) [23], Pro at 
m/z 587 (w,), and Tyr at m/z 742 (vs). In addition to 
the C-terminal ions, abundant N-terminal sequence 
ions up to b, and internal fragments up to five residues 
I 
,m 4c.l ,m bKl ,m fan wo loxl IIW IIW Ilrn lum IIca IHa InI ma 
long such as PAMVG (at m/z 456) are present. The 
sequence of this peptide is Phe-Tyr-Gly-Pro-Ala-Met- 
Val-Gly-Arg. Interestingly, the ion at M/Z 591 repre- 
sents a new type of fragmentation process for Met. The 
mass value corresponds to an a-CH,SH species. Simi- 
lar species were observed in other Met-containing pep- 
tides and in LSIMS-CID experiments as well. 
The MALDI-CID spectrum of the peptide with MH+ 
at m/z 876.5 is presented in Figure 11. As in the 
previous examples, the amino acid composition of the 
peptide was determined from the immonium ions 
noted: Arg, Ser, Pro, Ile-Leu, Phe, and Trp. Subtraction 
of the sum of these residue weights plus the elements 
of water (corresponding to the peptide termini) with 
the additional proton from the precursor ion mass 
value suggested that Ala is the missing residue. The 
sequence was established as previously described. 
Satellite fragments aided the sequencing effort at W/Z 
229 (w,) and 230 (v,) for the Ser, 388 (v,), 401 (w,), 
and 415 (w$ for Ile, and 500 (w,) for Pro, and N-termi- 
nal (such as b,, b,) and internal fragments (for 
example, PI, PIA and PIAS) provided additional con- 
firmation. The sequence of this peptide is Trp-Phe-Pro- 
Ile-Ala-Ser-Arg. 
Figure 9. MALDI-CID of a bacterial P450 tryptic 
peptide with MH+ at m/z 781.6. The amino acid 
sequence was determined from this spectrum to be 
Ser-Ser-Val-Phe-Trp-Arg. 
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Figure 10. MALDI-CID of a bacterial P45d tryptic 
peptide with MH+ at m/z 997.6. The amino acid 
sequence was determined from this spectrum to be 
Phe-Tyr-Gly-Pro-Ala-Met-Val-Gly-Arg. 
Discussion and Conclusions 
In this study CID spectra of synthetic MHC and other 
peptides obtained by MALDI and LSIMS were com- 
pared qualitatively with one another (Figures 3-5) and 
with the corresponding MALDI-PSD spectrum (Figure 
3). In addition, the power of a new tandem ion optical 
configuration (EBE-oa-TOF) designed to exploit the 
pulsed nature of the MALDI technique by using a 
100% duty cycle to achieve optimal sensitivity is 
demonstrated by the sequence analysis of three pep- 
tides obtained from an unknown bacterial cytochrome 
P450 enzyme. Even in this initial work, sensitivity is 
demonstrated for the standard peptides substance P 
and renin substrate with a loading of 1 pmol each to 
obtain the MALDI-CID spectra in Figures 7 and 8. 
These MALDI-CID experiments were carried out by 
using a center-of-mass collision energy approximately 
a factor of 6 higher than that routinely employed in 
LSIMS-CID experiments by using a tandem instrument 
of EBEB geometry [22]. The MALDI-CID spectra ac- 
quired for these unknown peptides displayed frag- 
mentation patterns directly comparable to those well 
established for four-sector high energy CID processes 
[5,21]. Abundant immonium and related ions revealed 
the amino acid composition of the peptides. Interest- 
ingly, although of little practical interpretative value, 
these same MALDI-CID spectra are devoid of side- 
chain losses from the pseudomolecular ion-abundant 
fragments commonly observed in LSIMS-CID spectra. 
The MALDI-CID spectra showed v, w, and/or d ions 
described earlier for high energy CID processes 1211. 
Concomitant with these ion series familiar from high 
energy CID spectra, additional ions are present that 
correspond to PSD-like fragmentation such as sequen- 
tial neutral losses from arginine-containing fragment 
ions (Figure 3). In addition, unusually abundant y-17 
ions were observed for C-terminal ions formed by 
peptide bond cleavage at a. Pro residue (Figures 5, 10, 
and 11). The virtually complete ion series with charge 
retention at the N-terminus in the spectra depicted in 
Figures 9 and 10 are also somewhat unusual for tryptic 
Figure 11. MALDI-CID of a bacterial P450 tryptic 
peptide with MH+ at m/z 876.5. The amino acid 
sequence was determined from this spectrum to be 
Trp-Phe-Pro-Ile-Ala-Ser-Arg. 
10 MEDZIHRADSZKY ET AL. 
peptides, especially with an Arg residue at the C- 
terminus. Similarly, the observation of b,,-, + H,O 
has been reported in both low and high energy CID 
spectra only for peptides with preferential charge re- 
tention at the N-terminus [5, 241. Although the CID 
spectra compared in Figures 3-5 were acquired on two 
tandem instruments of different geometry, we have 
evidence (based on LSIMS-CID spectra obtained from 
the same peptides on the two instruments compared; 
data not shown) that the unusual features of the 
MALDI-CID spectra are due to the different modes of 
ionization per se. Estimation of the sensitivity for 
MALDI-CID is presented in the data in Figures 6-8. 
The CID spectrum shown in Figure 6 was obtained 
from 500 laser shots taken at a single location on the 
sample probe tip that had been loaded with 5 pmol 
peptide, whereas the spectra of substance P (Figure 7) 
and renin substrate (Figure 8) were obtained by load- 
ing only 1 pmol of each peptide. Thus, it seems clear 
that femtomole level sensitivity will be achieved read- 
ily by incorporation of sample vials with limited vol- 
ume [251. 
The MALDI-CID spectrum of substance P acquired 
in an earlier experiment on a four-sector mass spec- 
trometer [ 131 did not show significant differences from 
that reported by LSIMS-CID [211. However, in the 
present work certain fragment ions were observed via 
MALDI-CID (Figure 7), such as b,, a7 + 1 - Q, and 
d which were not detected in the MALDI-CID 
fo7;Ksector experiment [13]. It is of interest to note that 
photodissociation (I’D) experiments also were per- 
formed on MALDI-generated ions with the same in- 
strumentation [14]. In the case of renin substrate, the 
MALDI-PD spectrum is significantly different from the 
published LSIMS-CID spectrum [261. Although the 
LSIMS-CID spectrum exhibits a complete d series (d, 
is missing because Pro residues cannot produce d 
ions), only d,, and d,, were recorded in the MALDI-PD 
spectrum. However, the MALDI-CID spectrum in this 
work does in fact closely resemble that obtained by the 
LSIMS-CID technique (see Figure 8). 
Further studies are underway to determine those 
factors that may influence the fragmentation observed 
in MALDI-CID experiments, which include the solid 
matrix selection, laser energy, and collision gas pres- 
sure. 
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